Similar articles

• Effects of the Rho-kinase inhibitor, fasudil, on pulmonary hypertension.

  Odagiri K, Watanabe H. Odagiri K, et al. Circ J. 2015;79(6):1213-4. doi: 10.1253/circj.CJ-15-0443. Epub 2015 Apr 30. Circ J. 2015. PMID: 25925979 No abstract available.
• Continuous intravertebral artery injection of fasudil hydrochloride in the treatment of cerebral vasospasm.

  Sarica FB. Sarica FB. Neurol India. 2011 Mar-Apr;59(2):151-3. doi: 10.4103/0028-3886.79121. Neurol India. 2011. PMID: 21483106 No abstract available.
• Modulation of cerebral malaria by fasudil and other immune-modifying compounds.

  Waknine-Grinberg JH, McQuillan JA, Hunt N, Ginsburg H, Golenser J. Waknine-Grinberg JH, et al. Exp Parasitol. 2010 Jun;125(2):141-6. doi: 10.1016/j.exppara.2010.01.005. Epub 2010 Jan 20. Exp Parasitol. 2010. PMID: 20093114
• Effect of Fasudil HCl, a protein kinase inhibitor, on cerebral vasospasm.

  Shibuya M, Asano T, Sasaki Y. Shibuya M, et al. Acta Neurochir Suppl. 2001;77:201-4. doi: 10.1007/978-3-7091-6232-3_42. Acta Neurochir Suppl. 2001. PMID: 11563286 Review. No abstract available.
• Safe and efficient drug delivery system with liposomes for intrathecal application of an antivasospastic drug, fasudil.

  Ishida T, Takanashi Y, Kiwada H. Ishida T, et al. Biol Pharm Bull. 2006 Mar;29(3):397-402. doi: 10.1248/bpb.29.397. Biol Pharm Bull. 2006. PMID: 16508135 Review.